Loading clinical trials...
Loading clinical trials...
Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation
This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.
Research procedures will coincide with clinical visits at institutional standards. As part of their clinical disease evaluation, participants will have blood, stool, and tissue collected as indicated by their disease course. Additional research samples or data will be collected during these visits. Participants will be asked to collect urine samples specifically for research.
Age
6 - 21 years
Sex
ALL
Healthy Volunteers
No
Seattle Children's Hospital
Seattle, Washington, United States
Start Date
May 10, 2024
Primary Completion Date
January 1, 2028
Completion Date
January 1, 2030
Last Updated
May 15, 2025
200
ESTIMATED participants
Esophagogastroduodenoscopy (EGD) with biopsy
DIAGNOSTIC_TEST
Colonoscopy w/ biopsy
DIAGNOSTIC_TEST
Lead Sponsor
Seattle Children's Hospital
Collaborators
NCT06226883
NCT07271069
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06975722